Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Phase I/II Trial of Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)in Children and Adolescents

NCT01713738 is registered in ClinicalTrials.gov with Neufeld, Ellis J, MD, PhD as lead sponsor.

NCT NCT01713738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01713738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Phase I/II Trial of Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)in Children and Adolescents
Lead sponsor
Neufeld, Ellis J, MD, PhD
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2003
Completion date
December 31, 2005
Enrollment
36 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic thrombocytopenic purpura (itp), immune thrombocytopenic purpura (itp)